The Difference Between Osteoarthritis and Rheumatoid Arthritis

The two diseases are entirely different.
Osteoarthritis is a condition that damages the joint and surrounding tissues.
Rheumatoid arthritis is an immune-mediated disease.
Osteoarthritis:
It is a degenerative process.
It usually occurs in elderly people.
It can also affect young individuals.
Cartilage in the joints is damaged or may become depleted.
It may affect movement of the joint.
Rheumatoid arthritis:
It is a systemic illness.
It can affect people at any age.
The immune system attacks the internal lining of the joints.
It leads to erosion of the joint or bone.
Key differences:
| Osteoarthritis | Rheumatoid arthritis |
| It may affect a single/multiple joints. | Characteristically symmetrical joint involvement (affects identical joints bilaterally). |
| Morning stiffness is brief (typically < 30 minutes) and worsens with exertion. | Morning stiffness is prolonged (typically > 30 to 60 minutes) and improves with movement. |
| Involves weight-bearing joints (knees, hips, spine) as well as the distal and proximal small joints of the hands. | It may affect smaller joints in fingers and toes. |
| It is confined to the joint or the tissue around it. | It has systemic effects. |
The treatment approach in osteoarthritis:
Drugs are not available to rebuild the cartilage.
The condition can be managed by controlling symptoms:
- Relieving pain/swelling
- Preserving joint function
The treatment includes:
Topical painkiller – Creams or sprays can be applied to the joint.
It may relieve joint pain and stiffness.
Oral NSAIDs – Painkillers can be taken to reduce acute pain or swelling.
Intra-articular injections – Corticosteroids may be injected into the joint.
They help bring short-term relief.
Joint replacement – The damaged joint is replaced with an artificial implant.
The treatment approach in rheumatoid arthritis:
It consists of targeted treatment to prevent joint damage.
Disease-modifying antirheumatic drugs (DMARDs)-
These interrupt the abnormal signaling pathways that may trigger the immune system.
They suppress the immune attack.
Corticosteroids or NSAIDs – These are used to relieve acute, sharp pain.
They help bring short-term relief.
Aprazer Healthcare is a pharmaceutical medicine manufacturer focused on rheumatology medicines.
We manufacture a range of affordable rheumatology medicines.
We export rheumatology medicines to the leading international markets.
Our flagship products include:
Targeted DMARD- Tofacitinib (Tofamark)
It is an advanced treatment drug for moderate and severe rheumatoid arthritis.
It primarily blocks JAK1, JAK2, and JAK3 enzymes.
It blocks intracellular signaling.
It suppresses the immune system.
Can a person suffer from both conditions?
Rheumatoid arthritis is an autoimmune condition.
Osteoarthritis may coexist depending on:
- Advancing age
- Obesity
- Injury to the joint
- Secondary osteoarthritis (resulting from rheumatoid joint damage)
Which is more severe: Rheumatoid arthritis or Osteoarthritis?
Rheumatoid arthritis is more complex.
- It is a systemic illness.
- It affects other body functions /parts
- It causes unpredictable flare-ups and periods of remission.
Osteoarthritis can still be severe, as it causes:
- Irreversible joint damage.
- Permanent loss of joint function.